Clinical Trial Update: Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating the combination of anti-CD19 CAR-T therapy with a BTK inhibitor to treat newly diagnosed high-risk chron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Anti-CD19 CAR-T therapy (CAR-T cell therapy targeting CD19)
• Bruton tyrosine kinase inhibitor

Snippet

Sponsor: The Affiliated Hospital of Xuzhou Medical University | Conditions: CLL, CAR-T Cell Therapy | NA | Status: RECRUITING